Compare FLGT & NOAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FLGT | NOAH |
|---|---|---|
| Founded | 2011 | 2005 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 579.9M | 653.4M |
| IPO Year | 2016 | 2010 |
| Metric | FLGT | NOAH |
|---|---|---|
| Price | $19.03 | $8.81 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 3 | 2 |
| Target Price | ★ $28.33 | $11.00 |
| AVG Volume (30 Days) | ★ 308.0K | 95.8K |
| Earning Date | 05-01-2026 | 05-27-2026 |
| Dividend Yield | N/A | ★ 5.66% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $18,730,000.00 | N/A |
| Revenue This Year | $10.09 | N/A |
| Revenue Next Year | $12.18 | $5.71 |
| P/E Ratio | ★ N/A | $13.29 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $13.46 | $8.14 |
| 52 Week High | $31.04 | $12.84 |
| Indicator | FLGT | NOAH |
|---|---|---|
| Relative Strength Index (RSI) | 48.95 | 47.44 |
| Support Level | $17.64 | $8.63 |
| Resistance Level | $20.10 | $9.08 |
| Average True Range (ATR) | 0.81 | 0.23 |
| MACD | -0.09 | 0.07 |
| Stochastic Oscillator | 71.56 | 92.31 |
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in the laboratory services business and the therapeutic development business. The laboratory services business, which generates key revenue, includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue, and Foreign.
Noah Holdings Ltd is a wealth management service provider offering comprehensive advisory services on investment and asset allocation, mainly for Mandarin-speaking high-net-worth (HNW) investors. The company's operating segments are Domestic public securities, Domestic asset management, Domestic insurance, Overseas wealth management, Overseas asset management, Overseas insurance and comprehensive services, and Headquarters. Maximum revenue is generated from its Domestic asset management business, which manages private equity funds, real estate equity funds, and private secondary products. The domestic asset management operations focus on managing primary market exits and cross-border ETF products in the secondary market. Geographically, it derives maximum revenue from Mainland China.